Company: CSTL
Filing Date: 2025-03-28
Form Type: PRE 14A
Source: 0001447362-25-000050
Chunk: 83

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-03-28
Form: PRE 14A
Chunk 83
---
 NEOs other than Mr. Maetzold in any fiscal year as our “Other NEOs” or our “Non-PEO NEOs.” Frank Stokes, Kristen M. Oelschlager and Tobin W. Juvenal were “Other NEOs” for each of the years 2021 through 2024. Frank Stokes and Bernhard E. Spiess, our former Chief Business Officer, were the “Other NEOs” for 2020. The dollar amounts are the total compensation for the covered fiscal year as reported in the Summary Compensation Table pursuant to Regulation S-K, item 402(c)(2)(x), as described under “—Summary Compensation Table.” In the case of the Other NEOs, the amounts reported are an average of the total compensation for the covered fiscal years.

(2) For each year, in determining both the compensation actually paid (“CAP”) for our PEO and the average CAP for our Other NEOs, we deducted or added back the following amounts from or to the total amounts of compensation reported in column (b) and column (d) for such year.

Mr. Maetzold’s CAP is calculated as follows:

| Year |     | Total Compensation from Summary Compensation Table 
 ($)                                                |           |     | Deduct: Stock Awards Value from Summary Compensation Table 
 ($)                                                        |           |     | Deduct: Option Awards Value from Summary Compensation Table 
 ($)                                                         |   |     | Add: Change in Fair Value of Awards Vesting During the Year 
 ($)*                                                        |         |     | Add: Change in Fair Value of Outstanding and Unvested Equity Awards 
 ($)*                                                                |         |     |           | Add: Year-End Fair Value of Equity Awards Granted During the Year 
 ($)*                                                              | Compensation Actually Paid 
 ($)                        |           |
| 2024 |     |                                                    | 6,941,074 |     |                                                            | 5,283,595 |     |                                                             | — |     |                                                             | 880,808 |     |                                                                     | 796,720 |     | 6,632,492 |                                                                   |                            | 9,967,499 |

#### 76Castle Biosciences 2025 Proxy Statement

#### Pay Versus Performance
Other NEOs average CAP are as follows:

| Year |     |           | Total Compensation from Summary Compensation Table 
 ($)                                                |     |           | Deduct: Stock Awards Value from Summary Compensation Table 
 ($)                                                        |     |   | Deduct: Option Awards Value from